Glycoengineering of pertuzumab and its impact on the pharmacokinetic/pharmacodynamic properties
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glycoengineering of pertuzumab and its impact on the pharmacokinetic/pharmacodynamic properties
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-04-11
DOI
10.1038/srep46347
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer
- (2016) A. Blythe Ryerson et al. CANCER
- One-step generation of triple knockout CHO cell lines using CRISPR/Cas9 and fluorescent enrichment
- (2015) Lise Marie Grav et al. Biotechnology Journal
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Biomarker assessment and molecular testing for prognostication in breast cancer
- (2015) Zuzana Kos et al. HISTOPATHOLOGY
- Antibody Glycosylation and Its Impact on the Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies and Fc-Fusion Proteins
- (2015) Liming Liu JOURNAL OF PHARMACEUTICAL SCIENCES
- Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression
- (2015) M. C. U. Cheang et al. ONCOLOGIST
- One-step generation of triple knockout CHO cell lines using CRISPR/Cas9 and fluorescent enrichment
- (2015) Lise Marie Grav et al. Biotechnology Journal
- In Vitro Glycoengineering of IgG1 and Its Effect on Fc Receptor Binding and ADCC Activity
- (2015) Marco Thomann et al. PLoS One
- Importance of the Side Chain at Position 296 of Antibody Fc in Interactions with FcγRIIIa and Other Fcγ Receptors
- (2015) Yuya Isoda et al. PLoS One
- Accelerating genome editing in CHO cells using CRISPR Cas9 and CRISPy, a web-based target finding tool
- (2014) Carlotta Ronda et al. BIOTECHNOLOGY AND BIOENGINEERING
- IgG-effector functions: “The Good, The Bad and The Ugly”
- (2014) Rick Kapur et al. IMMUNOLOGY LETTERS
- Targeted therapy for HER2 positive breast cancer
- (2013) Jason A Incorvati et al. Journal of Hematology & Oncology
- Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study
- (2013) Sandra M Swain et al. LANCET ONCOLOGY
- Recent advances in technology supporting biopharmaceutical production from mammalian cells
- (2012) M. Butler et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Pertuzumab in HER2-positive breast cancer
- (2012) Mehmet A.N. Sendur et al. CURRENT MEDICAL RESEARCH AND OPINION
- Correlation of ADCC activity with cytokine release induced by the stably expressed, glyco-engineered humanized Lewis Y-specific monoclonal antibody MB314
- (2012) Ralf Kircheis et al. mAbs
- Production, characterization and pharmacokinetic properties of antibodies with N-linked Mannose-5 glycans
- (2012) Marcella Yu et al. mAbs
- The Impact of Glycosylation on the Pharmacokinetics of a TNFR2:Fc Fusion Protein Expressed in Glycoengineered Pichia Pastoris
- (2012) Liming Liu et al. PHARMACEUTICAL RESEARCH
- Pharmacokinetics of IgG1 monoclonal antibodies produced in humanized Pichia pastoris with specific glycoforms: A comparative study with CHO produced materials
- (2011) Liming Liu et al. BIOLOGICALS
- High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans
- (2011) A. M. Goetze et al. GLYCOBIOLOGY
- Highly efficient deletion of FUT8 in CHO cell lines using zinc-finger nucleases yields cells that produce completely nonfucosylated antibodies
- (2010) Laetitia Malphettes et al. BIOTECHNOLOGY AND BIOENGINEERING
- Analytical and Functional Aspects of Antibody Sialylation
- (2010) Johannes Stadlmann et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Engineering host cell lines to reduce terminal sialylation of secreted antibodies
- (2010) Michael F. Naso et al. mAbs
- Post-translational Modifications Differentially Affect IgG1 Conformation and Receptor Binding
- (2010) Damian Houde et al. MOLECULAR & CELLULAR PROTEOMICS
- Investigating clearance mechanisms for recombinant activated factor VII in a perfused liver model
- (2010) Charlotte Theill et al. THROMBOSIS AND HAEMOSTASIS
- The unsialylated subpopulation of recombinant activated factor VII binds to the asialo-glycoprotein receptor (ASGPR) on primary rat hepatocytes
- (2010) Hanne M. Nielsen et al. THROMBOSIS AND HAEMOSTASIS
- Breast cancer biomarkers and HER2 testing after 10 years of anti-HER2 therapy
- (2009) J.S. Ross DRUG NEWS & PERSPECTIVES
- Glycosylation as a strategy to improve antibody-based therapeutics
- (2009) Roy Jefferis NATURE REVIEWS DRUG DISCOVERY
- Recombinant Antibodies as Therapeutic Agents
- (2008) Frederico Aires da Silva et al. BIODRUGS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started